Wang B - Search Results

1

Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics.

Liu Y, Xie QR, Wang B, Shao J, Zhang T, Liu T, Huang G, Xia W. Liu Y, et al. Among authors: wang b. Protein Cell. 2013 Sep;4(9):702-10. doi: 10.1007/s13238-013-3054-5. Epub 2013 Aug 27. Protein Cell. 2013. PMID: 23982738 Free PMC article.

2

Adjudin attenuates lipopolysaccharide (LPS)- and ischemia-induced microglial activation.

Shao J, Liu T, Xie QR, Zhang T, Yu H, Wang B, Ying W, Mruk DD, Silvestrini B, Cheng CY, Xia W. Shao J, et al. Among authors: wang b. J Neuroimmunol. 2013 Jan 15;254(1-2):83-90. doi: 10.1016/j.jneuroim.2012.09.012. Epub 2012 Oct 17. J Neuroimmunol. 2013. PMID: 23084372 Free PMC article.

3

Male contraceptive Adjudin is a potential anti-cancer drug.

Xie QR, Liu Y, Shao J, Yang J, Liu T, Zhang T, Wang B, Mruk DD, Silvestrini B, Cheng CY, Xia W. Xie QR, et al. Among authors: wang b. Biochem Pharmacol. 2013 Feb 1;85(3):345-55. doi: 10.1016/j.bcp.2012.11.008. Epub 2012 Nov 23. Biochem Pharmacol. 2013. PMID: 23178657 Free PMC article.

4

Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.

Yu W, Li J, Wang Q, Wang B, Zhang L, Liu Y, Tang M, Xu G, Yang Z, Wang X, Zhang J, Liu Y, Shi G. Yu W, et al. Among authors: wang x, wang b, wang q. Prostate. 2019 Aug;79(11):1304-1315. doi: 10.1002/pros.23838. Epub 2019 Jun 18. Prostate. 2019. PMID: 31212367

5

Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.

Wang Q, Peng R, Wang B, Wang J, Yu W, Liu Y, Shi G. Wang Q, et al. Among authors: wang j, wang b. Cancer Biomark. 2018;22(3):533-541. doi: 10.3233/CBM-181196. Cancer Biomark. 2018. PMID: 29843216 Free PMC article.

6

KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.

Wang B, Jing T, Jin W, Chen J, Wu C, Wang M, Liu Y. Wang B, et al. Among authors: wang m. J Exp Clin Cancer Res. 2020 Aug 27;39(1):170. doi: 10.1186/s13046-020-01684-x. J Exp Clin Cancer Res. 2020. PMID: 32854746 Free PMC article.

7

ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.

Xu X, Wang B, Liu Y, Jing T, Xu G, Zhang L, Kun Jiao, Chen Z, Xiang L, Xu C, Yang Z, Liu Y. Xu X, et al. Among authors: wang b. Cancer Lett. 2022 Jul 1;537:215640. doi: 10.1016/j.canlet.2022.215640. Epub 2022 Mar 13. Cancer Lett. 2022. PMID: 35296440

8

USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.

Qian Y, Wang B, Ma A, Zhang L, Xu G, Ding Q, Jing T, Wu L, Liu Y, Yang Z, Liu Y. Qian Y, et al. Among authors: wang b. Sci Rep. 2016 Sep 16;6:33039. doi: 10.1038/srep33039. Sci Rep. 2016. PMID: 27633997 Free PMC article.

9

Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma.

Jing T, Wang B, Yang Z, Liu Y, Xu G, Xu X, Jiao K, Chen Z, Xiang L, Zhang L, Liu Y. Jing T, et al. Among authors: wang b. Cancer Lett. 2021 Oct 10;518:266-277. doi: 10.1016/j.canlet.2021.07.044. Epub 2021 Jul 30. Cancer Lett. 2021. PMID: 34339800

10

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.

Yang Z, Xu G, Wang B, Liu Y, Zhang L, Jing T, Tang M, Xu X, Jiao K, Xiang L, Fu Y, Tang D, Zhang X, Jin W, Zhuang G, Zhao X, Liu Y. Yang Z, et al. Among authors: wang b. Nat Commun. 2021 Aug 11;12(1):4852. doi: 10.1038/s41467-021-25032-5. Nat Commun. 2021. PMID: 34381028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,965 results

Search Page

Filters